button bars forest bayes pooled summary circles
 
DCR

metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)

versus pegylated liposomal doxorubicin
avelumab alone vs. pegylated liposomal doxorubicin 1 certainty unassessable+102%
avelumab plus pegylated liposomal doxorubicin vs. pegylated liposomal doxorubicin 1 certainty unassessable+179%

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons